Table 1.
Demographic characteristics in the per-protocol immunogenicity cohort
| |
Primary vaccine group |
|||
|---|---|---|---|---|
|
AS03
A
-H5N1 |
Non-adjuvanted-H5N1 |
|||
| |
N = 954
†
|
N = 245
†
|
||
| |
Heterologous booster group per-protocol immunogenicity cohort |
|||
|
Month 6 |
Month 12 |
Month 36 |
Month 6 |
|
| N = 256 | N = 186 | N = 387 | N = 229 | |
| Mean age, years |
33.3 |
35.4 |
38.0 |
33.5 |
| (SD, range) |
(10.16; 19–58) |
(9.24; 21–59) |
(9.74; 21–62) |
(9.17; 19–58) |
| Male, n (%) |
117 (45.7) |
89 (48.4) |
201 (51.9) |
115 (50.2) |
| Female, n (%) |
139 (54.3) |
95 (51.6) |
186 (48.1) |
114 (49.8) |
| Central/South Asian Heritage |
1 (0.4) |
2 (1.1) |
3 (0.8) |
5 (2.2) |
| East Asian Heritage |
154 (60.2) |
115 (62.5) |
225 (58.1) |
135 (59.0) |
| South East Asian heritage |
101 (39.5) |
66 (35.9) |
159 (41.1) |
88 (38.4) |
| Arabic/North African Heritage | – | – | – | 1 (0.4) |
†Total vaccinated cohort in initial study; SD, standard deviation; N, number of subjects in group.